The suspension of the Alzheimer's study might be one of the saddest aspects of this FDA issue. I've mentioned before that my doctor recommended Anatabloc to two patients with mild Alzheimer's and both of those patients reported definite results*. I know my doc ordered enough Anatabloc for his own use for 6 months, but it might be hard to have elderly people stock up. And obviously while the study is on hold, the effects of Alzheimer's are not.
*the Anatabloc was added to their regimen; it did not replace it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.